AVITHRAPID
banner
avithrapid.bsky.social
AVITHRAPID
@avithrapid.bsky.social
The EU-funded project AVITHRAPID aims to develop broad spectrum antiviral therapeutics for infectious diseases with epidemic – and subsequently pandemic – potential.
AVITHRAPID evolves! 🧬
A new Training section is now live on our website - open to everyone interested in infectious diseases, small molecules, and AI-driven antiviral discovery.
🔗 Explore it here: avithrapid.eu/training/
#AVITHRAPID #ScienceEducation #AI #DrugDiscovery
November 12, 2025 at 8:35 AM
Small molecules are a flexible and scalable tool for new and resistant viruses.

AVITHRAPID puts them at the core of our antiviral strategy.

#Antivirals #Innovation #AVITHRAPID
November 4, 2025 at 12:11 PM
avithrapid.eu/europe...

At the end of September, Frascati Scienza celebrated 20 years of science during the European Researchers’ Night 2025 🇪🇺
Through Tor Vergata University, AVITHRAPID engaged with the public, sharing advances in antiviral research.
#AVITHRAPID #ERN2025 #ScienceOutreach
European Researchers' Night at Frascati Scienza - AVITHRAPID project
Frascati Scienza celebrated 20 years of science, passion, and curiosity with the 2025 edition of the European Researchers’ Night. The event filled squares, schools, museums, and institutions throughout Italy with a week packed with events dedicated to scientific dissemination: a journey through STEAM – Science, Technology, Engineering, Art, and Mathematics – culminating on September 26, 2025, with the European Researchers’ Night. The European Researchers’ Night was the opportunity to introduce the AVITHRAPID project to the research community and the general public. It brought its results to researchers closer to the public, attracting over 30.000 visitors to all events, while increasing the interest of young people in science and research careers and showing how researchers’ work affects our daily lives. Francesca Ceccherini Silberstein with her team from University of Rome Tor Vergata distributed and illustrated some dissemination material prepared for this specific event. Poster
avithrapid.eu
October 24, 2025 at 6:15 PM
20th October AVITHRAPID hosted a seminar with the APPEAL project, fostering an inspiring exchange of ideas within the #HorizonEU framework.
October 23, 2025 at 2:24 PM
Today is Global Handwashing Day.

Hand hygiene prevents infections, yet the development of antivirals and small molecules is essential to tackle emerging viruses and safeguard public health.
#GlobalHandwashingDay #HealthInnovation #DrugDiscovery #Science
October 15, 2025 at 12:18 PM
Small molecules are key to the future of antivirals: fast to develop, easy to deliver, globally accessible.

At AVITHRAPID, we put them at the core of our mission to protect against emerging viruses.

#AVITHRAPID #Antivirals #DrugDiscovery
October 9, 2025 at 7:02 AM
💊 Small molecules = game-changer for antivirals.

Where is their biggest impact?
- Emerging viral threats
- Resistant strains
- Global access
- Other / not sure

Vote & share your view in the comments!

#AVITHRAPID #Antivirals #DrugDiscovery #Biotech
September 30, 2025 at 7:19 AM
AVITHRAPID will be at the European Researchers’ Night on 26 Sept in Italy 🇮🇹.
Our scientists will share how small molecules and advanced research shape the future of antivirals.
#AVITHRAPID #ERN2025 #Innovation
September 23, 2025 at 3:29 PM
AVITHRAPID will be part of Settimana della Scienza in Italy (20–27 Sept) 🇮🇹 through our partner Tor Vergata University.
At their stand, you can learn more about our mission and the future of antiviral drug discovery.

Program: www.frascatiscienza....

#AVITHRAPID #ScienceWeek #ERN2025
September 18, 2025 at 7:38 AM
AI is changing healthcare 🚀

But when it comes to drug discovery, which impact do you see first?
- Speed of development
- Personalized therapies
- Cost savings
- Still unclear

Cast your vote ⬇️

#AVITHRAPID #Innovation #DrugDiscovery
September 15, 2025 at 12:19 PM
Our recent poll sparked a key conversation:
🧬 Vaccines prevent
💊 Antivirals treat
Both are essential pillars of #globalhealth.
At #AVITHRAPID, we’re working to accelerate antiviral research - ensuring faster, safer, and smarter therapies that complement vaccines.
September 11, 2025 at 1:08 PM
🧪 Vaccines prevent. Antivirals treat.
Both are vital — but which will shape the future of infectious disease? 🦠
Vaccines
Antivirals
Both equally
Not sure
👉 Vote in the poll and share your thoughts in the comments!
Your perspective matters for the future of global health.
September 8, 2025 at 6:05 PM
AVITHRAPID and Area Science Park just published an annoucement about their new partnership to drive antiviral and preventive innovation.
The MoU strengthens Europe’s scientific response to future health threats.
📰 Read more: avithrapid.eu/avithr...
#AVITHRAPID #ScienceFeed #PublicHealth #Innovation
AVITHRAPID and Area Science Park Join Forces to Drive Antiviral Innovation - AVITHRAPID project
AVITHRAPID has signed a new Memorandum of Understanding (MoU) with Area Science Park, a leading Italian research hub, to accelerate innovation in antiviral therapeutics and preventive strategies. This agreement marks a significant step forward in strengthening Europe’s ability to anticipate, prevent, and respond to future infectious disease threats. At its core lies a shared ambition: […]
avithrapid.eu
September 3, 2025 at 6:43 PM
AVITHRAPID is advancing broad-spectrum antivirals across Europe — and we’re sharing it with you.

Subscribe to our newsletter for updates on research, events, partnerships & more.
📩 avithrapid.eu/newsle...
#AVITHRAPID #ScienceFeed #PublicHealth
August 27, 2025 at 4:39 PM
Broad-spectrum antivirals (BSAs) target host or conserved viral parts, working across virus families. They deploy fast and aid pandemic prep without needing virus ID. Trade-offs: toxicity, resistance risk, less precision. Still, BSAs could be key for unpredictable outbreaks. #HealthTech #Science
August 19, 2025 at 3:32 PM
It’s #WorldBreastfeedingWeek - a reminder that science must reflect everyone’s needs.
At #AVITHRAPID, we believe preparedness means inclusion, equity and long-term impact.
#ScienceFeed #HealthEquity
August 13, 2025 at 11:43 AM
Who’s behind AVITHRAPID?
A Europe-wide network of labs, hospitals, and research centres working together on broad-spectrum antivirals.
August 5, 2025 at 12:39 PM
From hepatitis C to tomorrow’s viruses: AVITHRAPID builds on proven science to prepare for future outbreaks.

#WorldHepatitisDay #ScienceFeed
July 28, 2025 at 10:31 AM
AVITHRAPID has signed an MoU with @AREASciencePark to strengthen Europe’s preparedness for future pandemics.
The partnership will boost rapid antiviral development, training, funding strategy & long-term impact.

#AVITHRAPID #ScienceFeed #PandemicResponse
July 25, 2025 at 5:04 PM
What’s next for AVITHRAPID?
Following our meeting in Berlin , we’re entering a critical phase — improving existing antivirals while evaluating new broad-spectrum compounds.
Stronger preparedness through innovation.

#AVITHRAPID #PandemicPreparedness #OneHealth
July 18, 2025 at 6:58 PM
Reposted by AVITHRAPID
🧪 Last 16-17 June, the #AVITHRAPID team met in Berlin to plan next steps in antiviral preparedness! Great science, strong collaboration — and a few laughs too 😄
📸 Highlights below!
#HorizonEU #DrugRepurposing #PandemicPreparedness
July 10, 2025 at 6:13 AM
🧪 Last 16-17 June, the #AVITHRAPID team met in Berlin to plan next steps in antiviral preparedness! Great science, strong collaboration — and a few laughs too 😄
📸 Highlights below!
#HorizonEU #DrugRepurposing #PandemicPreparedness
July 10, 2025 at 6:13 AM
Neglected tropical diseases (NTDs) affect over 1.5 billion people worldwide, yet treatment options remain limited. Broad-spectrum antivirals offer a promising solution. Let’s push for innovation and progress. Stay informed on the latest updates—subscribe to our newsletter at www.avithrapid.eu
June 12, 2025 at 6:30 AM
Our consortium partners are meeting next week in Berlin for an exciting session to exchange ideas, review progress, and plan upcoming work. Are you part of a team focused on antiviral development? Reach out to explore future collaborations with us! #AVITHRAPID #Collaboration #Innovation
June 11, 2025 at 6:30 AM
Market gaps in broad-spectrum #antivirals are clear: limited #discovery platforms, resistance concerns, clinical trial barriers, and access issues. It’s time to bridge these gaps and innovate to protect global health. Subscribe to our newsletter: www.avithrapid.eu
June 10, 2025 at 6:30 AM